ALPA LABORATORIES LTD. - 532878 - Disclosure Under Regulation 29 (2) Of SEBI SAST Regulations,2011.
The company has received disclosure under regulation 29 (2) of SEBI SAST Regulations,2011 along with Form C under regulation 7(2) SEBI Prohibition of Insider Regulations,2015. ALPA LABORATORIES LTD. - 532878 - Quarterly Financial Results For The Period Ended December 31,2018.
Alpa Laboratories Limited has submitted the Quarterly results for the period ended December 31,2018. ALPA LABORATORIES LTD. - 532878 - Board Meeting Intimation for Alpa Laboratories Limited, Intimation Of Board Meeting To Be Held On 09Th February, 2019.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2019 ,inter alia, to consider and approve The unaudited financial results of the company for the quarter ended December 31,2018. Alpa Laboratories Ltd - 532878 - Shareholding for the Period Ended December 31, 2018
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Alpa Laboratories Ltd - 532878 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Megha NeemaDesignation :- Company Secretary and Compliance Officer Quarterly Un-Audited Financial Results For The Period Ended September 30, 2018.
Alpa laboratories has submitted the Quarterly results for the period ended September 30, 2018. Board Meeting Intimation for Alpa Laboratories Limited Has Informed Exchange Of The Board Meeting Scheduled To Be Held On November 03,2018 At The Registered Office Of The Company To Approve The Un-Audited Quarterly Results
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2018 ,inter alia, to consider and approve Un-audited standalone quarterly results for the quarter ended September,2018 along with limited review report. Disclosure Under Regulation 7(3) Of Compliance Certificate For The Half Year Ended September 30,2018
Alpa Laboratories has submitted the disclosure under regulation 7 (3) of Compliance Certificate for the half year ended September 30,2018. Shareholding for the Period Ended September 30, 2018
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- MEGHA NEEMADesignation :- Company Secretary and Compliance Officer